CAMBRIDGE, Mass., June 13, 2022 (GLOBE NEWSWIRE) -- Contrast agents used in MRI scans to improve the clarity of imaging for diagnostic accuracy, accumulate in the brain and body of every patient, and ...

Expecting mothers who undergo an MRI in their first trimester shouldn’t have much to worry about if it was a standard one, according to a recent study of more than 1.4 million women. But an MRI that ...

NEW YORK (CBSNewYork)-- There is new information about whether or not MRI scans are safe for pregnant women as the first large-scale study on the effect of MRI's on mother and baby has been released.

Women exposed to magnetic resonance imaging (MRI) during the first trimester of pregnancy do not experience an increased risk for harm to the fetus relative to women who were not exposed. The ...

New research suggests gadolinium retention may be more widespread and may be present in many more, or possibly all, patients exposed to gadolinium-based contrast agents, according to new research.

Some of these studies evaluated GBCA use for durations >1 year and showed that gadolinium is retained in organs such as the brain, bones, and skin. After evaluating the risk of brain deposits with ...

Gadolinium-enhanced MRI is associated with an increased risk of stillbirth or neonatal death, as well as rheumatologic, inflammatory, or infiltrative skin conditions. MRI use in the first trimester of ...

Nanoscientists have demonstrated a method for loading nanoparticles with iron ions to create MRI contrast agents that outperform gadolinium chelates, the mainstay contrast agent that is facing ...

Gadolinium-based contrast agents (GBCAs) used in MRI and angiography contain a chelated form of the toxic heavy metal that was assumed to clear the body shortly after intravenous administration. [1] ...

Depending on the thermodynamic complex stability, addition of the trivalent metal salts may cause transmetallation or recomplexing in the MRI contrast agents, resulting in the release of toxic Gd 3+ ...

The gadolinium market in Spain is expected to grow at a CAGR of 3.9% by 2034. Spain's leadership in medical tourism is supported by a reputable private healthcare sector, which attracts advanced ...